These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7076440)

  • 1. Contrast enhancement dynamic CT measurements and a mathematical model.
    Cassel DM; Young SW; Turner R
    Invest Radiol; 1982; 17(1):82-9. PubMed ID: 7076440
    [No Abstract]   [Full Text] [Related]  

  • 2. Computed tomography of rabbit V2 carcinoma after intraarterial contrast enhancement.
    Young SW; Enzmann D; Marglin SI
    J Comput Assist Tomogr; 1979 Apr; 3(2):185-8. PubMed ID: 429626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
    Young SW; Turner RJ; Castellino RA
    Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):291-5. PubMed ID: 6600346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic hepatic CT: uniphasic and biphasic contrast medium injection protocols.
    Drop A
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():195-204. PubMed ID: 11205764
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit.
    Burgener FA; Violante MR
    Invest Radiol; 1979; 14(5):410-4. PubMed ID: 500305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT contrast enhancement of kidney V2 carcinoma after norepinephrine and acetylcholine injection.
    Marincek B; Muller HH; Young SW
    Invest Radiol; 1981; 16(6):487-90. PubMed ID: 7319754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional imaging of the liver. New information from dynamic CT.
    Axel L; Dean PB; Moss AA; Stansberry D
    Invest Radiol; 1984; 19(1):23-9. PubMed ID: 6323343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic CT of hepatic masses with intravenous and intraarterial contrast material.
    Moss AA; Dean PB; Axel L; Goldberg HI; Glazer GM; Friedman MA
    AJR Am J Roentgenol; 1982 May; 138(5):847-52. PubMed ID: 6282093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer imaging by scanned projection radiography.
    Cassel DM; Young SW; Brody WR; Hall AL
    J Comput Assist Tomogr; 1981 Aug; 5(4):557-62. PubMed ID: 7263995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-arterial dynamic computed tomography in characterizing liver metastases of colorectal cancer].
    Flentje M; Hohenberger P; Adolph J; Kober B
    Rofo; 1986 Sep; 145(3):263-7. PubMed ID: 3020626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and characterization of hepatocellular carcinoma: value of dynamic CT during the arterial dominant phase with uniphasic contrast medium injection.
    Cho JS; Kwag JG; Oh YR; Han SD; Song CJ
    J Comput Assist Tomogr; 1996; 20(1):128-34. PubMed ID: 8576463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined CT during the arterial portography and CT arteriography.
    Itai Y
    Abdom Imaging; 1998; 23(3):337-8. PubMed ID: 9569310
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver enhancement techniques in computed tomography. A comparison of intravenous bolus, computed tomographic portography, and iodipamide ethyl ester particle injections in a canine model.
    Lee FT; Sproat IA; Rappe AH; Violante MR; Bronson JP
    Invest Radiol; 1994 Jun; 29 Suppl 2():S289-92. PubMed ID: 7928259
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
    Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
    Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast enhancement of focal hepatic lesions in CT: effect of size and histology.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):297-301. PubMed ID: 6600347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT.
    Freeny PC; Marks WM
    Radiology; 1986 Sep; 160(3):613-8. PubMed ID: 3016794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT evaluation of suspected hepatic metastases: comparison of techniques for i.v. contrast enhancement.
    Paushter DM; Zeman RK; Scheibler ML; Choyke PL; Jaffe MH; Clark LR
    AJR Am J Roentgenol; 1989 Feb; 152(2):267-71. PubMed ID: 2783503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast enhancement technique for dynamic hepatic computed tomographic scanning.
    Foley WD; Berland LL; Lawson TL; Smith DF; Thorsen MK
    Radiology; 1983 Jun; 147(3):797-803. PubMed ID: 6844616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic.
    Sadigh G; Applegate KE; Baumgarten DA
    Acad Radiol; 2014 Jan; 21(1):113-25. PubMed ID: 24331274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.